Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Frequency Therapeutics, Inc. (FREQ)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
0.3813-0.0137 (-3.47%)
At close: 03:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Performance Outlook
Previous Close0.3950
Open0.3811
Bid0.3820 x 900
Ask0.3900 x 1800
Day's Range0.3811 - 0.4298
52 Week Range0.3260 - 5.5900
Volume28,263
Avg. Volume1,733,831
Market Cap13.925M
Beta (5Y Monthly)0.70
PE Ratio (TTM)N/A
EPS (TTM)-1.9000
Earnings DateNov 06, 2023 - Nov 10, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for FREQ

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Frequency Therapeutics, Inc.
    Daily – Vickers Top Buyers & Sellers for 07/05/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    3 months agoArgus Research
View more
  • Business Wire

    Frequency Therapeutics Provides Business Updates and Second Quarter 2023 Financial Results

    LEXINGTON, Mass., August 10, 2023--Frequency Therapeutics, Inc. (Nasdaq: FREQ) today announced business updates and financial results for the second quarter ended June 30, 2023.

  • Zacks

    Frequency (FREQ) Up 77% on Merger Deal With Korro Bio

    Post-merger, Frequency (FREQ) focuses on advancing RNA editing programs. This combined entity is set to operate under the name Korro Bio, which will apply to trade on the NASDAQ under the ticker symbol KRRO.

  • Benzinga

    Why Are Frequency Therapeutics Shares Surging Today

    Korro Bio Inc and Frequency Therapeutics Inc (NASDAQ: FREQ) announced an all-stock merger transaction. Under the merger agreement's terms, stockholders of Korro Bio will receive newly issued shares of Frequency Therapeutics. Frequency Therapeutics has discontinued developing its remyelination program for Multiple Sclerosis as it explores strategic alternatives for the program. Suppose Frequency Therapeutics has not otherwise monetized its remyelination program before the closing of the proposed

Advertisement
Advertisement